115 related articles for article (PubMed ID: 17121228)
41. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.
Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4511-8. PubMed ID: 17671137
[TBL] [Abstract][Full Text] [Related]
42. Novel bioabsorbable salicylate-based polymer as a drug-eluting stent coating.
Jabara R; Chronos N; Robinson K
Catheter Cardiovasc Interv; 2008 Aug; 72(2):186-94. PubMed ID: 18651646
[TBL] [Abstract][Full Text] [Related]
43. Tetramethylpyrazine-eluting stents prevented in-stent restenosis in a porcine model.
Ma G; Ding S; Feng Y; Shen C; Chen L; Chen Z
J Cardiovasc Pharmacol; 2007 Aug; 50(2):201-5. PubMed ID: 17703137
[TBL] [Abstract][Full Text] [Related]
44. Biodistribution and safety studies of hDel-1 plasmid-based gene therapy in mouse and rabbit models.
Quezada A; Larson J; French M; Ponce R; Perrard J; Durland R; Coleman M
J Pharm Pharmacol; 2004 Feb; 56(2):177-85. PubMed ID: 15005876
[TBL] [Abstract][Full Text] [Related]
45. Site-specific targeting of nanoparticle prednisolone reduces in-stent restenosis in a rabbit model of established atheroma.
Joner M; Morimoto K; Kasukawa H; Steigerwald K; Merl S; Nakazawa G; John MC; Finn AV; Acampado E; Kolodgie FD; Gold HK; Virmani R
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1960-6. PubMed ID: 18688017
[TBL] [Abstract][Full Text] [Related]
46. Gene delivery into hepatocytes with the preS/liposome/DNA system.
Wang Z; Yuan Z; Jin L
Biotechnol J; 2008 Oct; 3(9-10):1286-95. PubMed ID: 18830969
[TBL] [Abstract][Full Text] [Related]
47. Liposomal surface coatings of metal stents for efficient non-viral gene delivery to the injured vasculature.
Ganly S; Hynes SO; Sharif F; Aied A; Barron V; McCullagh K; McMahon J; McHugh P; Crowley J; Wang W; O'Brien T; Greiser U
J Control Release; 2013 Apr; 167(2):109-19. PubMed ID: 23403396
[TBL] [Abstract][Full Text] [Related]
48. Polyelectrolyte multilayers promote stent-mediated delivery of DNA to vascular tissue.
Saurer EM; Jewell CM; Roenneburg DA; Bechler SL; Torrealba JR; Hacker TA; Lynn DM
Biomacromolecules; 2013 May; 14(5):1696-704. PubMed ID: 23597075
[TBL] [Abstract][Full Text] [Related]
49. Reductive amination as a strategy to reduce adenovirus vector promiscuity by chemical capsid modification with large polysaccharides.
Espenlaub S; Wortmann A; Engler T; Corjon S; Kochanek S; Kreppel F
J Gene Med; 2008 Dec; 10(12):1303-14. PubMed ID: 18837065
[TBL] [Abstract][Full Text] [Related]
50. The efficacy of nanoscale poly[bis(trifluoroethoxy) phosphazene] (PTFEP) coatings in reducing thrombogenicity and late in-stent stenosis in a porcine coronary artery model.
Satzl S; Henn C; Christoph P; Kurz P; Stampfl U; Stampfl S; Thomas F; Radeleff B; Berger I; Grunze M; Richter GM
Invest Radiol; 2007 May; 42(5):303-11. PubMed ID: 17414526
[TBL] [Abstract][Full Text] [Related]
51. The effect of a layer-by-layer chitosan-heparin coating on the endothelialization and coagulation properties of a coronary stent system.
Meng S; Liu Z; Shen L; Guo Z; Chou LL; Zhong W; Du Q; Ge J
Biomaterials; 2009 Apr; 30(12):2276-83. PubMed ID: 19168214
[TBL] [Abstract][Full Text] [Related]
52. Effects of oral prednisone after stenting in a rabbit model of established atherosclerosis.
Ribichini F; Joner M; Ferrero V; Finn AV; Crimins J; Nakazawa G; Acampado E; Kolodgie FD; Vassanelli C; Virmani R
J Am Coll Cardiol; 2007 Jul; 50(2):176-85. PubMed ID: 17616304
[TBL] [Abstract][Full Text] [Related]
53. Mouse growth and differentiation factor-5 protein and DNA therapy potentiates intervertebral disc cell aggregation and chondrogenic gene expression.
Cui M; Wan Y; Anderson DG; Shen FH; Leo BM; Laurencin CT; Balian G; Li X
Spine J; 2008; 8(2):287-95. PubMed ID: 17974491
[TBL] [Abstract][Full Text] [Related]
54. Layer-by-layer assembly of poly(ethyleneimine) and plasmid DNA onto transparent indium-tin oxide electrodes for temporally and spatially specific gene transfer.
Yamauchi F; Kato K; Iwata H
Langmuir; 2005 Aug; 21(18):8360-7. PubMed ID: 16114943
[TBL] [Abstract][Full Text] [Related]
55. Colloidally stable novel copolymeric system for gene delivery in complete growth media.
Agarwal A; Vilensky R; Stockdale A; Talmon Y; Unfer RC; Mallapragada SK
J Control Release; 2007 Aug; 121(1-2):28-37. PubMed ID: 17614155
[TBL] [Abstract][Full Text] [Related]
56. Conjugation of an antibody to cross-linked fibrin for targeted delivery of anti-restenotic drugs.
Thomas AC; Campbell JH
J Control Release; 2004 Dec; 100(3):357-77. PubMed ID: 15567502
[TBL] [Abstract][Full Text] [Related]
57. Conjugational transfer system to shuttle giant DNA cloned by Bacillus subtilis genome (BGM) vector.
Kuroki A; Ohtani N; Tsuge K; Tomita M; Itaya M
Gene; 2007 Sep; 399(1):72-80. PubMed ID: 17560740
[TBL] [Abstract][Full Text] [Related]
58. Osteogenic effects of bone-morphogenetic-protein-2 plasmid gene transfer.
Seol YJ; Kim KH; Park YJ; Lee YM; Ku Y; Rhyu IC; Lee SJ; Han SB; Chung CP
Biotechnol Appl Biochem; 2008 Jan; 49(Pt 1):85-96. PubMed ID: 17608624
[TBL] [Abstract][Full Text] [Related]
59. Local vascular toxicokinetics of stent-based drug delivery.
Tesfamariam B
Toxicol Lett; 2007 Jan; 168(2):93-102. PubMed ID: 17169513
[TBL] [Abstract][Full Text] [Related]
60. Reduction of late in-stent stenosis in a porcine coronary artery model by cobalt chromium stents with a nanocoat of polyphosphazene (Polyzene-F).
Stampfl U; Sommer CM; Thierjung H; Stampfl S; Lopez-Benitez R; Radeleff B; Berger I; Richter GM
Cardiovasc Intervent Radiol; 2008; 31(6):1184-92. PubMed ID: 18704573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
